Go Pro
→ Trump’s secret China deal (From Porter & Company) (Ad)tc pixel Free SUN Stock Alerts

Surgical Innovations Group (SUN) Competitors

Surgical Innovations Group logo
GBX 0.46 0.00 (0.00%)
As of 07/17/2026 11:00 AM Eastern
Compare

SUN vs. BRY, MXC, HNR, NOG, and WRES

Should you buy Surgical Innovations Group stock or one of its competitors? MarketBeat compares Surgical Innovations Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Surgical Innovations Group include Brady (BRY), Argent BioPharma (MXC), Highlands Natural Resources (HNR), Nostrum Oil & Gas (NOG), and W Resources (WRES). These companies are all part of the "petroleum and natural gas" industry.

How does Surgical Innovations Group compare to Brady?

Brady (LON:BRY) and Surgical Innovations Group (LON:SUN) are both small-cap petroleum and natural gas companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

Surgical Innovations Group is trading at a lower price-to-earnings ratio than Brady, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brady£22.16M0.00N/A-£3.70N/A
Surgical Innovations Group£11.60M0.37N/A-£0.10N/A

In the previous week, Brady's average media sentiment score of 0.00 equaled Surgical Innovations Group'saverage media sentiment score.

Company Overall Sentiment
Brady Neutral
Surgical Innovations Group Neutral

2.8% of Surgical Innovations Group shares are owned by institutional investors. 22.2% of Surgical Innovations Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Brady has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Brady's return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
BradyN/A N/A N/A
Surgical Innovations Group -4.96%-6.04%-3.03%

Summary

Brady and Surgical Innovations Group tied by winning 4 of the 8 factors compared between the two stocks.

How does Surgical Innovations Group compare to Argent BioPharma?

Argent BioPharma (LON:MXC) and Surgical Innovations Group (LON:SUN) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

Argent BioPharma has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Argent BioPharma's return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Argent BioPharmaN/A N/A -58.96%
Surgical Innovations Group -4.96%-6.04%-3.03%

1.2% of Argent BioPharma shares are owned by institutional investors. Comparatively, 2.8% of Surgical Innovations Group shares are owned by institutional investors. 8.2% of Argent BioPharma shares are owned by insiders. Comparatively, 22.2% of Surgical Innovations Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Surgical Innovations Group has higher revenue and earnings than Argent BioPharma. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Argent BioPharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Argent BioPharma£1.32M0.00-£17.02M-£1.66N/A
Surgical Innovations Group£11.60M0.37N/A-£0.10N/A

Argent BioPharma has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market. Comparatively, Surgical Innovations Group has a beta of 0.65, meaning that its share price is 35% less volatile than the broader market.

In the previous week, Argent BioPharma's average media sentiment score of 0.00 equaled Surgical Innovations Group'saverage media sentiment score.

Company Overall Sentiment
Argent BioPharma Neutral
Surgical Innovations Group Neutral

Summary

Surgical Innovations Group beats Argent BioPharma on 6 of the 9 factors compared between the two stocks.

How does Surgical Innovations Group compare to Highlands Natural Resources?

Highlands Natural Resources (LON:HNR) and Surgical Innovations Group (LON:SUN) are both small-cap petroleum and natural gas companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

2.8% of Surgical Innovations Group shares are held by institutional investors. 22.2% of Surgical Innovations Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Highlands Natural Resources' average media sentiment score of 0.00 equaled Surgical Innovations Group'saverage media sentiment score.

Company Overall Sentiment
Highlands Natural Resources Neutral
Surgical Innovations Group Neutral

Surgical Innovations Group is trading at a lower price-to-earnings ratio than Highlands Natural Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Highlands Natural Resources£1.02M0.00N/A-£4.90N/A
Surgical Innovations Group£11.60M0.37N/A-£0.10N/A

Highlands Natural Resources has a net margin of 0.00% compared to Surgical Innovations Group's net margin of -4.96%. Highlands Natural Resources' return on equity of 0.00% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Highlands Natural ResourcesN/A N/A N/A
Surgical Innovations Group -4.96%-6.04%-3.03%

Summary

Highlands Natural Resources and Surgical Innovations Group tied by winning 4 of the 8 factors compared between the two stocks.

How does Surgical Innovations Group compare to Nostrum Oil & Gas?

Surgical Innovations Group (LON:SUN) and Nostrum Oil & Gas (LON:NOG) are both small-cap petroleum and natural gas companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

Surgical Innovations Group has a net margin of -4.96% compared to Nostrum Oil & Gas' net margin of -184.95%. Nostrum Oil & Gas' return on equity of 88.74% beat Surgical Innovations Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
Nostrum Oil & Gas -184.95%88.74%1.53%

Nostrum Oil & Gas has a consensus target price of GBX 4, suggesting a potential upside of 14.29%. Given Nostrum Oil & Gas' stronger consensus rating and higher probable upside, analysts plainly believe Nostrum Oil & Gas is more favorable than Surgical Innovations Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Surgical Innovations Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Nostrum Oil & Gas
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

2.8% of Surgical Innovations Group shares are owned by institutional investors. Comparatively, 9.7% of Nostrum Oil & Gas shares are owned by institutional investors. 22.2% of Surgical Innovations Group shares are owned by company insiders. Comparatively, 44.0% of Nostrum Oil & Gas shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Surgical Innovations Group has higher earnings, but lower revenue than Nostrum Oil & Gas. Surgical Innovations Group is trading at a lower price-to-earnings ratio than Nostrum Oil & Gas, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.37N/A-£0.10N/A
Nostrum Oil & Gas£120.77M0.05-£121.71M-£134.00N/A

In the previous week, Surgical Innovations Group's average media sentiment score of 0.00 equaled Nostrum Oil & Gas'average media sentiment score.

Company Overall Sentiment
Surgical Innovations Group Neutral
Nostrum Oil & Gas Neutral

Surgical Innovations Group has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market. Comparatively, Nostrum Oil & Gas has a beta of 0.751, indicating that its stock price is 25% less volatile than the broader market.

Summary

Nostrum Oil & Gas beats Surgical Innovations Group on 9 of the 12 factors compared between the two stocks.

How does Surgical Innovations Group compare to W Resources?

Surgical Innovations Group (LON:SUN) and W Resources (LON:WRES) are both small-cap petroleum and natural gas companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings.

Surgical Innovations Group has a beta of 0.65, meaning that its stock price is 35% less volatile than the broader market. Comparatively, W Resources has a beta of 1.05, meaning that its stock price is 5% more volatile than the broader market.

In the previous week, Surgical Innovations Group's average media sentiment score of 0.00 equaled W Resources'average media sentiment score.

Company Overall Sentiment
Surgical Innovations Group Neutral
W Resources Neutral

Surgical Innovations Group has higher revenue and earnings than W Resources. Surgical Innovations Group is trading at a lower price-to-earnings ratio than W Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Surgical Innovations Group£11.60M0.37N/A-£0.10N/A
W Resources£3.47M0.00-£6.06M-£6.10N/A

Surgical Innovations Group has a net margin of -4.96% compared to W Resources' net margin of -174.96%. Surgical Innovations Group's return on equity of -6.04% beat W Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Surgical Innovations Group-4.96% -6.04% -3.03%
W Resources -174.96%-33.02%-2.04%

2.8% of Surgical Innovations Group shares are owned by institutional investors. Comparatively, 4.6% of W Resources shares are owned by institutional investors. 22.2% of Surgical Innovations Group shares are owned by company insiders. Comparatively, 28.0% of W Resources shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

W Resources beats Surgical Innovations Group on 5 of the 9 factors compared between the two stocks.

Get Surgical Innovations Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SUN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SUN vs. The Competition

Export
MetricSurgical Innovations GroupMedical Devices IndustryMedical SectorLON Exchange
Market Cap£4.27M£2.15B£6.86B£2.78B
Dividend Yield2.63%2.64%2.67%6.14%
P/E Ratio-4.5815.0427.25368.19
Price / Sales0.37128.82584.4884,555.41
Price / Cash5.0315.9929.0527.89
Price / Book0.464.5510.707.53
Net IncomeN/A£144.75M£3.59B£5.89B
7 Day Performance1.78%-0.49%-1.00%5.68%
1 Month Performance1.55%1.10%1.66%4.92%
1 Year Performance-31.74%-4.48%25.64%61.89%

Surgical Innovations Group Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SUN
Surgical Innovations Group
N/AGBX 0.46
flat		N/A-31.7%£4.27M£11.60MN/A80
BRY
Brady
N/AN/AN/AN/A£15.17M£22.16MN/A1,370
MXC
Argent BioPharma
N/AN/AN/AN/A£9.65M£1.32MN/A5
HNR
Highlands Natural Resources
N/AN/AN/AN/A£6.95M£1.02MN/A16
NOG
Nostrum Oil & Gas
0.7651 of 5 stars		GBX 3.20
-8.5%		GBX 4
+25.0%		N/A£5.28M£120.77MN/A30

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:SUN) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My next big call (under $1)
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...
Crypto 101 Media | Sponsoredtc pixel
Trump’s $250 Bill – See Immediately
Former Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...
Stansberry Research | Sponsoredtc pixel
Ex-CIA Insider: “Prepare for a Mid-Term Meltdown”
Former CIA and Pentagon advisor Jim Rickards - who correctly called the 2008 recession, Trump's 2016 election,...
Paradigm Press | Sponsoredtc pixel
This same-day trade is getting a lot of attention
Zero-days-to-expiration trades happen every single day - and most traders either ignore them or use them wrong...
Base Camp Trading | Sponsoredtc pixel
Print this and keep it by your screen
Ever been right about a stock's direction and still lost money on the trade? It's almost never bad luck - it's...
Profits Run | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel